Compare RXST & GUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RXST | GUG |
|---|---|---|
| Founded | 1997 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 524.6M | 511.2M |
| IPO Year | 2021 | N/A |
| Metric | RXST | GUG |
|---|---|---|
| Price | $11.46 | $15.35 |
| Analyst Decision | Hold | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $11.30 | N/A |
| AVG Volume (30 Days) | ★ 824.6K | 108.9K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.67% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $142,085,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.26 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 10.75 | N/A |
| 52 Week Low | $6.32 | $12.71 |
| 52 Week High | $37.13 | $15.06 |
| Indicator | RXST | GUG |
|---|---|---|
| Relative Strength Index (RSI) | 49.18 | 49.86 |
| Support Level | $10.46 | $15.24 |
| Resistance Level | $13.14 | $15.67 |
| Average True Range (ATR) | 0.67 | 0.20 |
| MACD | -0.25 | 0.00 |
| Stochastic Oscillator | 36.23 | 33.33 |
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
Guggenheim Active Allocation Fund is a diversified closed-end management investment company. The fund's investment objective is to maximize total return through a combination of current income and capital appreciation. The company invests in both fixed-income and other debt instruments selected from a variety of sectors and credit qualities, and may also invest in equities. It uses tactical asset allocation models to determine the optimal allocation of its assets between fixed-income and equity securities. A majority of its investments are made in corporate bonds and the rest in senior floating rate interests, asset-backed securities, preferred stocks, and other securities.